Program Analysis
Rutgers University-New Brunswick's Biotechnology graduates start at $56,509/yr — above the $48,121 national average, though not by a wide margin.
At 8.2x the cost of in-state tuition, the ten-year earnings outlook represents a strong return. Not exceptional, but meaningfully positive.
AI risk is moderate — 48% task exposure — and the 10% scenario spread suggests disruption would dent but not destroy the earnings outlook.
Loan repayment is a non-issue here — $21,500 in median debt clears quickly against $56,509 in annual earnings.
At #10 out of 18 programs, Rutgers University-New Brunswick's financial outcomes for Biotechnology trail the majority of peers. The value case depends on other factors.